Market Overview:
The global heparin API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cardiovascular diseases and cancer, rising geriatric population, and growing demand for heparin APIs in emerging markets. By type, the hepatic sodium segment is expected to account for the largest share of the global heparin API market in 2018. By application, UFH is expected to account for the largest share of the global heparin API market in 2018. North America is estimated to dominate the global heparin API market in 2018 owing to factors such as high prevalence of cardiovascular diseases and cancer and well-established healthcare infrastructure.
Product Definition:
Heparin API is a medication which is used to prevent or treat blood clots. It can be given as an injection or taken by mouth. It works by stopping the blood from clotting too quickly.
Heparin Sodium:
Heparin sodium is a low molecular weight heparin used as an anticoagulant drug in medical practice. It is manufactured by chemical modification of natural occurring heparin, which is extracted from the plasma of animal origin including human blood. Heparin sodium has several advantages over conventional heparins such as it can be given intravenously and it has a longer half-life than other synthetic heparins.
Heparin Calcium:
Heparin calcium is a form of anticoagulant drug used to prevent blood clotting. It works by interfering with the normal function of coagulation factors in the body. Heparin calcium market is segmented on the basis of product and end-use industry. On the basis of product, it can be categorized into low molecular weight (LM), unfractionated, and low-molecular-weight (UFM) heparin calcium drugs.
Application Insights:
The ultrafiltration and fluid-loss therapies segment dominated the global heparin API market in terms of revenue share in 2017. This is owing to a rise in demand for these therapies as an alternative to blood transfusion. Heparin, when administered through an intravenous (IV) line, helps reduce the risk of death and complications associated with bleeding due to reduced blood viscosity. As a result, it has been widely used for various conditions such as acute kidney failure (AKF), liver failure and heart attack along with other life-threatening diseases that require low molecular weight heparin or unfractionated heparin as treatment option.
UFH is expected to be the fastest growing application segment over the forecast period owing to its ability to act quickly without causing any adverse effects on cardiovascular system like coumadin does.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, increasing healthcare expenditure, and rising awareness about cardiovascular diseases (CVDs) treatment. In addition, presence of key players such as Pfizer Inc.; Johnson & Johnson Services, Inc.; and BMS will boost the growth over the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period due to factors such as improving healthcare infrastructure and growing patient awareness about advanced therapies for CVDs management. Moreover, government initiatives for providing free medicines are anticipated to fuel revenue generation in this region.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) and other medical conditions requiring heparin therapy
- Growing demand for heparin API in emerging markets
- Rising number of product approvals and launches by key players
- Proliferation of research activities on heparin API to develop novel therapeutics
- Technological advancements in the manufacturing process of heparin API
Scope Of The Report
Report Attributes
Report Details
Report Title
Heparin API Market Research Report
By Type
Heparin Sodium, Heparin Calcium, Other
By Application
UFH, LMWH
By Companies
Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen Oss, King-friend Biochemical Pharmaceutical, Bioibérica, Dongcheng Biochemicals, Jiulong Biochemicals, Hepalink, Xinbai, Yino Pharma Limited
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Heparin API Market Report Segments:
The global Heparin API market is segmented on the basis of:
Types
Heparin Sodium, Heparin Calcium, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
UFH, LMWH
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hepalink
- Changshan Pharm
- Qianhong Bio-pharma
- Opocrin
- Pfizer
- Aspen Oss
- King-friend Biochemical Pharmaceutical
- Bioibérica
- Dongcheng Biochemicals
- Jiulong Biochemicals
- Hepalink
- Xinbai
- Yino Pharma Limited
Highlights of The Heparin API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Heparin Sodium
- Heparin Calcium
- Other
- By Application:
- UFH
- LMWH
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Heparin API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Heparin is a blood thinner that helps to prevent clots from forming in the blood.
Some of the major companies in the heparin api market are Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen Oss, King-friend Biochemical Pharmaceutical, Bioib©rica, Dongcheng Biochemicals, Jiulong Biochemicals, Hepalink, Xinbai, Yino Pharma Limited.
The heparin api market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Heparin API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Heparin API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Heparin API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Heparin API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Heparin API Market Size & Forecast, 2020-2028
4.5.1 Heparin API Market Size and Y-o-Y Growth
4.5.2 Heparin API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Heparin Sodium
5.2.2 Heparin Calcium
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 UFH
6.2.2 LMWH
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Heparin API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Heparin API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Heparin Sodium
9.6.2 Heparin Calcium
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 UFH
9.10.2 LMWH
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Heparin Sodium
10.6.2 Heparin Calcium
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 UFH
10.10.2 LMWH
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Heparin Sodium
11.6.2 Heparin Calcium
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 UFH
11.10.2 LMWH
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Heparin Sodium
12.6.2 Heparin Calcium
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 UFH
12.10.2 LMWH
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Heparin Sodium
13.6.2 Heparin Calcium
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 UFH
13.10.2 LMWH
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Heparin API Market: Competitive Dashboard
14.2 Global Heparin API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hepalink
14.3.2 Changshan Pharm
14.3.3 Qianhong Bio-pharma
14.3.4 Opocrin
14.3.5 Pfizer
14.3.6 Aspen Oss
14.3.7 King-friend Biochemical Pharmaceutical
14.3.8 Bioibérica
14.3.9 Dongcheng Biochemicals
14.3.10 Jiulong Biochemicals
14.3.11 Hepalink
14.3.12 Xinbai
14.3.13 Yino Pharma Limited
